Search results
Results from the WOW.Com Content Network
In 1911, the anaesthetist Arthur Ernest Guedel first described the use of self-administration of a nitrous oxide and oxygen mix. It was not until 1961 that the first paper was published by Michael Tunstall and others, describing the administration of a pre-mixed 50:50 nitrous oxide and oxygen mix, which led to the commercialisation of the product.
It is for this reason that Entonox, a 50:50 gaseous mixture of nitrous oxide and oxygen, is suitable for use by para-medical staff such as ambulance officers: it provides sufficient nitrous oxide for pain relief with sufficient oxygen to avoid hypoxia. [7] [8]
Nitrous oxide (N 2 O), commonly referred to as laughing gas, along with various street names, is an inert gas which can induce euphoria, dissociation, hallucinogenic states of mind, and relaxation when inhaled. [1] Nitrous oxide has no acute biochemical or cellular toxicity and is not metabolized in humans or other mammals.
Nitrous cut-off or oxygen failure protection device, OFPD: the flow of medical nitrous-oxide is dependent on oxygen pressure. This is done at the regulator level. In essence, the nitrous-oxide regulator is a 'slave' of the oxygen regulator. i.e., if oxygen pressure is lost then the other gases can not flow past their regulator.
He was unsuccessful in finding gold, and returned to the East. In partnership with two dentists, he set up the Colton Dental Association, which promoted the use of nitrous oxide in dental procedures and became a thriving business. Between 1864 and 1897, Colton and his associates used nitrous oxide in tens of thousands of tooth extractions.
Cryo-S Painless cryoanalgesia device is the next generation of apparatus used by many experts in the field since 1992. The working medium for Cryo-S Painless is carbon dioxide: CO 2 (−78 °C) or nitrous oxide: N 2 O (−89 °C), very efficient and easy to use gases. Cryo-S Painless is controlled by a microprocessor and all the parameters are ...
These effects occur because of the contraction of alveolar volume associated with the uptake of the nitrous oxide. Previous explanations by Edmond I. Eger and Robert K. Stoelting have appealed to an extra-inspired tidal volume due to a potential negative intrapulmonary pressure associated with the uptake of the nitrous oxide. [2]
Monitoring of methemoglobin needed when nitric oxide is in use. Nitric oxide with oxygen (O 2) in combination produces another by-product chemical compound nitrogen dioxide (NO 2). The higher the oxygen concentration and nitric oxide therapy duration and lower ventilator flow rate the higher amount of NO 2 will be produced. NO 2 is toxic and its